Last Posted: Sep 05, 2019
- What you need to know about ovarian cancer
CDC, 2019 - Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li Boxuan et al. Gene 2019 Sep 714143993 - Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Tomao Federica et al. Gynecologic oncology 2019 154(1) 138-143 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson Heidi D et al. JAMA 2019 322(7) 666-685 - USPSTF Recommendation Expands Cancer Screening Pool, Concerns Still Remain
KL Kahl, Cure, August 26, 2019 - Inherited cancer syndromes in 220 Italian ovarian cancer patients.
Carnevali I et al. Cancer genetics 2019 Sep 23755-62 - A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
LaDuca Holly et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Aug - Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome.
McGarragle Kaitlin M et al. Hereditary cancer in clinical practice 2019 1724 - Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
Foretov? Lenka et al. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32(Supplementum2) 6-13 - BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.
Bu Hualei et al. The journal of obstetrics and gynaecology research 2019 Aug
.png)
No hay comentarios:
Publicar un comentario